Indirect Calorimeter Based Study in Patients With Liver Cirrhosis

Liver Cirrhoses Clinical Trial

— METALIC  

Official title:

Metabolic and Clinical Effects of Enteral Nutrition Therapy: Measured Versus Estimated Energy and Substrate Requirements in Critically Ill Cirrhotics-A Randomized Controlled Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03871894
• Other study ID #: ILBS-METALIC01
• Status: Completed
• Phase: N/A
• Start date: March 12, 2019
• Est. completion date: August 31, 2022

Study information

• Verified date: September 2022
• Source: Institute of Liver and Biliary Sciences, India
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Part I- Observational study In the first part , investigator would investigate and compare the energy requirements and substrate utilization in healthy subjects and in patients with liver cirrhosis of various etiologies across the disease severity state viz compensated, stable decompensated, critically ill cirrhotics. The investigator would also enroll patients with chronic kidney disease, critically ill patients of acute liver failure or acute on chronic liver failure as disease controls. Part II- Randomized Controlled Study All the eligible, critically ill cirrhotic patients on mechanical ventilator support would be randomized to a control group (receiving the nutritional therapy as per the standard enteral nutritional practice in a critical care setting) or the intervention group (receiving enteral nutrition based on proposed measured requirements by Indirect calorimetry (IC) given till the patient is in ICU(Intensive care unit). The IC would be done thrice a week in both groups.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 83
• Est. completion date: August 31, 2022
• Est. primary completion date: August 31, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 70 Years

Eligibility

Inclusion Criteria:

Disease groups:

• Patients with liver cirrhosis (diagnosis established based on routine clinical, biochemical and at least radiological, endoscopic or histological parameters.) admitted in Liver coma Intensive care unit and those admitted in ward.

Disease controls:

• Patients with Acute liver failure (diagnosis established based on routine clinical, biochemical and at least radiological parameters) admitted in Liver coma Intensive care unit
• Patients with severe acute pancreatitis (diagnosis established based on routine clinical, biochemical and at least radiological parameters) admitted in Liver coma Intensive care unit

Healthy Controls:

• Healthy subjects- Relatives of patients with no known chronic diseases (Chronic obstructive pulmonary disease, Coronary artery disease, Type 2 diabetes, Hypertension, Hypothyroidism, Koch's disease) or not on any long term medications.
• Patients with liver cirrhosis (diagnosis established based on routine clinical, biochemical and at least radiological, endoscopic or histological parameters.) admitted in Liver coma Intensive care unit who require mechanical ventilation

Exclusion Criteria:

• Age<18 years
• Active upper gastrointestinal bleeding
• If there are conditions which precluded IC, such as an FiO2 >60 %, failure to cooperate, agitation, seizure activity, spasticity, or positive end-expiratory pressure (PEEP) >10 mmHg.
• Pregnant women
• Refused to consent/ inability to obtain informed consent.
• Known long standing diabetic
• If there is any evidence of medical/surgical instability
• Hepatocellular carcinoma Extrahepatic malignancies
• With persistent gastrointestinal dysfunction and ileus
• Patients who would be readmitted to the ICU
• Known long standing diabetic
• Terminally ill patients on high inotropic support
• Acute liver failure
• If there is any evidence of medical/surgical instability
• If patients are taking any portion of nutrition by mouth.
• Pregnant women
• Refused to consent/ inability to obtain informed consent.
• Patient on CRRT- continuous renal replacement therapy
• Severe co morbidities such as Chronic kidney disease requiring maintenance dialysis, COPD and Cardiac pathologies (Acute myocardial infarction, heart failure, ).
• Hepatocellular carcinoma Extrahepatic malignancies
• Moribund patient with likely survival <24 hours
• Patients enrolled in other drug trials.

Related Conditions & MeSH terms

• Fibrosis
• Liver Cirrhoses
• Liver Cirrhosis

Intervention

Other:
• Indirect calorimetry based nutritional intervention till patient in ICU(Intensive care unit)
Nutrition therapy based on measured energy expenditure by indirect calorimetry (IC) done alternate day till patient on ventilatory support and protein intake 1.5 g/kg IBW/day
• Standard and fixed nutritional intervention till patient in ICU
Fixed standard nutritional therapy 35-40 Kcal/Kg IBW/day and 1.5 g protein /Kg IBW/Day till patient on ventilator

Locations

Country	Name	City	State
India	ILBS	New Delhi	Delhi

Sponsors (1)

Lead Sponsor	Collaborator
Institute of Liver and Biliary Sciences, India

Country where clinical trial is conducted

India, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Part 1: An Observational study	Study groups : Healthy controls; Disease Groups; Patients with liver cirrhosis (compensated and decompensated); Critically ill cirrhotics on mechanical ventilator support; patients with chronic kidney disease (CKD) (stable,non dialyzed, non oliguric outpatients); Critically ill patients with Acute liver failure (ALF) on mechanical ventilator support; Critically ill patients with Acute on chronic liver failure(ACLF) on mechanical ventilator support; Severe acute pancreatitis on mechanical ventilator support; Comparison of the prevalence of hyper and hypo metabolism in patients with chronic liver disease(CLD) and healthy controls and other disease groups.	One day (Observational)
Primary	Part 2: A Randomized controlled trial	Study group:Critically ill Cirrhotic: Diagnosed cases of liver cirrhosis with 2 or more organ failures (liver + renal/circulatory or respiratory failures) requiring ICU admission and on mechanical ventilator support meeting inclusion and exclusion criteria The difference in the duration of mechanical ventilation in critically ill ventilated patients with liver cirrhosis when the nutritional therapy delivered as per estimated energy requirements versus measured requirements	From date of enrollment until the date of ICU discharge /Leaving against medical advice, date of death from any cause, or off ventilatory support whichever comes first, assessed up to 28 days.
Secondary	Change in metabolic profile	The effect of nutritional therapy as per estimated energy requirements versus measured requirements in critically ill ventilated patients with liver cirrhosis on the Insulin resistance, ketone bodies, Non-esterified fatty acids (NEFA), amino acids profile and blood sugar levels would be studied	The metabolic parameters would be assessed at the baseline, Day 7 and at Day 15 of enrollment
Secondary	Change in inflammatory milieu	The effect of nutritional therapy as per estimated energy requirements versus measured requirements in critically ill ventilated patients with liver cirrhosis on the levels of interleukin 6 (IL-6), Tumor necrosis factor(TNF alfa), CRP(C reactive protein)would be studied	The inflammatory markers would be assessed at the baseline, Day 7 and at Day 15 of enrollment
Secondary	Change in clinical parameters	The effect of nutritional therapy as per estimated energy requirements versus measured requirements in critically ill ventilated patients with liver cirrhosis ondevelopment of new onset infection, resolution of sepsis, renal function and length of stay in the ICU/hospital would be studied	The clinical parameters would be assessed daily from the date of enrollment until the date of ICU discharge, date of death from any cause, or out of mechanical ventilatory support whichever comes first, assessed up to 28 days.
Secondary	Change in ventilatory and arterial blood gas parameters	The effect of nutritional therapy as per estimated energy requirements versus measured requirements in critically ill ventilated patients with liver cirrhosis on ventilator parameters (FiO2, PEEP, PF ratio) and arterial blood gas parameters( PO2, PCO2, lactate, SpO2) would be studied	The ventilatory and arterial blood gas parameters would be assessed daily from the date of enrollment until the date of ICU discharge, date of death from any cause, or out of mechanical ventilatory support whichever comes first, assessed up to 28 days.
Secondary	Change in nutritional parameters	The effect of nutritional therapy as per estimated energy requirements versus measured requirements in critically ill ventilated patients with liver cirrhosis on nutritional parameters( NUTRIC score, feed intolerance and would be studied	The nutritional parameters would be assesses at regular intervals maximum upto 28 days
Secondary	The association between energy metabolism, nutritional status and disease severity in patients with CLD	The association between energy metabolism (resting energy expenditure- REE, substrate utilization and macronutrient oxidation), nutritional status (by body composition and anthropometry)and disease severity in patients with CLD (CTP and MELD scores) would be studied	one day (Observational)